Papillary Thyroid Cancer News and Research

RSS
Papillary Thyroid Cancer is cancer that forms in follicular cells in the thyroid and grows in small finger-like shapes. It grows slowly, is more common in women than in men, and often occurs before age 45. It is the most common type of thyroid cancer.
Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Scientists discover new protein that drive metastasis of cancer cells

Scientists discover new protein that drive metastasis of cancer cells

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Blood levels of microRNAs may serve as diagnostic tool for thyroid cancer, but more research needed

Blood levels of microRNAs may serve as diagnostic tool for thyroid cancer, but more research needed

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

Discoveries pave way for use of new therapies for advanced thyroid cancer

Discoveries pave way for use of new therapies for advanced thyroid cancer

Low-risk thyroid cancers are overdiagnosed and overtreated

Low-risk thyroid cancers are overdiagnosed and overtreated

Researchers say testing for BRAF V600E-positive tumors needed for aggressive thyroid cancer

Researchers say testing for BRAF V600E-positive tumors needed for aggressive thyroid cancer

BRAF genetic mutation increases mortality among patients with papillary thyroid cancer

BRAF genetic mutation increases mortality among patients with papillary thyroid cancer

Radioactive iodine benefits selected papillary thyroid cancer patients

Radioactive iodine benefits selected papillary thyroid cancer patients

Age 65 and above may be more accurate marker for prognosis of papillary thyroid cancer

Age 65 and above may be more accurate marker for prognosis of papillary thyroid cancer

Radioactive iodine should only be used in treatment of some patients with papillary thyroid cancer

Radioactive iodine should only be used in treatment of some patients with papillary thyroid cancer

Argentine President does not have cancer

Argentine President does not have cancer

CLND may help reduce papillary thyroid cancer recurrence rates

CLND may help reduce papillary thyroid cancer recurrence rates

New rapid method for detection of BRAF V600E gene in thyroid tissue

New rapid method for detection of BRAF V600E gene in thyroid tissue

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

ATA announces five recipients of 2011 thyroid cancer research grants

ATA announces five recipients of 2011 thyroid cancer research grants

Delayed treatment could prove effective in certain medical conditions

Delayed treatment could prove effective in certain medical conditions

FDA grants Exelixis XL184 orphan drug designation for treatment of medullary thyroid cancer

FDA grants Exelixis XL184 orphan drug designation for treatment of medullary thyroid cancer